CMS has taken a step in its ongoing efforts to manage healthcare costs by extending the negotiation timeline for Medicare drug price cuts. This decision, announced on Wednesday, is part of a broader strategy to ensure that the process is both fair and effective. CMS is tasked with selecting the costliest prescription medications for negotiation by February 1, with new prices set to take effect in 2027. This initiative is being closely monitored by pharmaceutical manufacturers, particularly those producing the 15 drugs most likely to be chosen for these negotiations.
